Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126393062 | 12639306 | 2 | F | 20160803 | 20160810 | 20160810 | PER | PHEH2016US019711 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160810 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126393062 | 12639306 | 1 | PS | VALSARTAN. | VALSARTAN | 1 | Oral | UNK | U | 20665 | |||||||||
| 126393062 | 12639306 | 2 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126393062 | 12639306 | 3 | SS | METOPROLOL. | METOPROLOL | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126393062 | 12639306 | 1 | Atrial fibrillation |
| 126393062 | 12639306 | 2 | Product used for unknown indication |
| 126393062 | 12639306 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126393062 | 12639306 | Drug ineffective | |
| 126393062 | 12639306 | Hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |